|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
EP0183901B1
(de)
*
|
1984-11-27 |
1992-07-08 |
BEHRINGWERKE Aktiengesellschaft |
Bifunktionelle Haptene, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
US5576195A
(en)
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
ES2150428T3
(es)
|
1987-04-27 |
2000-12-01 |
Unilever Nv |
Ensayos de union especifica.
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
JPH02111798A
(ja)
*
|
1988-10-20 |
1990-04-24 |
Fuji Photo Film Co Ltd |
蛋白質修飾物
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
DE69232002T2
(de)
*
|
1991-06-07 |
2002-06-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassays unter Verwendung von markierten Hapten-Analogen
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
AU668159B2
(en)
|
1992-05-29 |
1996-04-26 |
Lilly Industries Limited |
Pharmaceutical compounds
|
|
DE69323244T2
(de)
|
1992-06-26 |
1999-07-08 |
Johnson & Johnson Clinical Diagnostics, Inc., Rochester, N.Y. |
Immunotests unter Verwendung von markierten Thyronin-Analogen
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
ATE288270T1
(de)
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
|
DE69535855D1
(de)
|
1994-06-10 |
2008-11-20 |
Oklahoma Med Res Found |
Calciumbindende rekombinante antikörper gegen protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
WO1998059233A1
(en)
|
1997-06-23 |
1998-12-30 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
JPH1151935A
(ja)
*
|
1997-08-06 |
1999-02-26 |
Aisin Seiki Co Ltd |
複数種類のターゲット分子の同時検出方法
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
RU2181297C2
(ru)
*
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
|
US7163681B2
(en)
*
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US7288390B2
(en)
*
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
ATE492565T1
(de)
|
2002-01-31 |
2011-01-15 |
Randox Lab Ltd |
Immunogene, antikörper und konjugate für ketamin und dessen metaboliten
|
|
DE60334364D1
(de)
|
2002-02-21 |
2010-11-11 |
Univ California |
Behandlungsverfahren unter verwendung von anti-cd22-antikörpern
|
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
|
WO2003082877A1
(en)
|
2002-03-28 |
2003-10-09 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
US20040127489A1
(en)
|
2002-07-29 |
2004-07-01 |
David Pickar |
Novel antipsychotic combination therapies and compositions useful therein
|
|
DK1546134T3
(da)
|
2002-08-05 |
2007-09-10 |
Lilly Co Eli |
Piperazinsubstituerede arylbenzodiazepiner
|
|
US20040193446A1
(en)
|
2003-03-27 |
2004-09-30 |
Mayer Steven Lloyd |
System and method for managing a patient treatment program including a prescribed drug regimen
|
|
US7271252B2
(en)
|
2003-04-22 |
2007-09-18 |
Roche Diagnostics Operations, Inc. |
Reagents for detecting efavirenz
|
|
KR101351122B1
(ko)
|
2003-05-09 |
2014-01-14 |
듀크 유니버시티 |
Ｃｄ２０-특이적 항체 및 이를 이용한 방법
|
|
PL1658277T3
(pl)
*
|
2003-08-18 |
2012-10-31 |
H Lundbeck As |
Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek
|
|
WO2005028458A1
(en)
|
2003-09-23 |
2005-03-31 |
Fermion Oy |
Preparation of quetiapine
|
|
AU2004278414B2
(en)
|
2003-10-01 |
2012-05-24 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
|
BRPI0415531B8
(pt)
|
2003-10-23 |
2021-05-25 |
Otsuka Pharma Co Ltd |
formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
|
|
EP1706743B1
(en)
*
|
2003-12-12 |
2009-11-18 |
Inverness Medical Switzerland GmbH |
Assay
|
|
GB0328892D0
(en)
*
|
2003-12-12 |
2004-01-14 |
Inverness Medical Switzerland |
Positive signal assay for analytes
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
JP2005292087A
(ja)
*
|
2004-04-05 |
2005-10-20 |
Shionogi & Co Ltd |
５’−デオキシ−５’−メチルチオアデノシンに対する抗体
|
|
WO2005103250A1
(ja)
|
2004-04-26 |
2005-11-03 |
Takami Matsuyama |
葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
JP5249748B2
(ja)
|
2005-04-25 |
2013-07-31 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
無菌３−［２−［４−（６−フルオロ−１，２−ベンズイソオキサゾール−３−イル）−１−ピペリジニル］エチル］−６，７，８，９−テトラヒドロ−９−ヒドロキシ−２−メチル−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンパルミチン酸エステルの製造
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE0501418L
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
EP2078731A4
(en)
|
2006-10-20 |
2012-08-01 |
Forerunner Pharma Res Co Ltd |
ANTI-HB-EGF ANTIBODY AS PHARMACEUTICAL COMPOSITION CONTAINING ACTIVE SUBSTANCE
|
|
EP2077860B1
(en)
|
2006-10-25 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd |
Psychotropic agents having glutamate nmda activity
|
|
US20080138842A1
(en)
*
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
ES2405364T3
(es)
|
2006-12-29 |
2013-05-30 |
Abbott Laboratories |
Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
|
|
CN101600716A
(zh)
|
2007-01-08 |
2009-12-09 |
阿特维斯集团公司 |
用于制备9-羟基-3-(2-氯乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮盐酸盐的改进方法
|
|
CN101245065B
(zh)
|
2007-02-14 |
2010-05-19 |
江苏恩华药业股份有限公司 |
制备苯并异噁唑衍生物的方法及其中间体
|
|
CA2699062A1
(en)
|
2007-09-27 |
2009-04-02 |
Novartis Ag |
Drug monitoring assay
|
|
US8133743B2
(en)
|
2007-10-19 |
2012-03-13 |
Roche Diagnostics Operations, Inc. |
Phenobarbital derivatives useful in immunoassay
|
|
CA2943923C
(en)
*
|
2008-04-29 |
2018-02-06 |
Psychemedics Corporation |
Solid phase multi-analyte assay
|
|
EP3338795A1
(en)
|
2008-07-21 |
2018-06-27 |
Probiodrug AG |
Diagnostic antibody assay
|
|
AU2009279372A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
AU2009305203B2
(en)
|
2008-10-14 |
2013-03-07 |
Entasis Therapeutics Limited |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
WO2010096117A2
(en)
*
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
AU2010206376B2
(en)
*
|
2009-01-26 |
2012-10-18 |
Egalet Ltd. |
Controlled release formulations with continuous efficacy
|
|
EP2406288B1
(en)
|
2009-03-10 |
2016-12-14 |
Baylor Research Institute |
Antigen presenting cell targeted vaccines
|
|
CA2937222C
(en)
|
2009-06-25 |
2019-06-04 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds
|
|
RU2554854C9
(ru)
|
2009-07-31 |
2017-02-03 |
Асцендис Фарма Ас |
Биоразлагаемые нерастворимые в воде гидрогели на основе полиэтиленгликоля
|
|
US20120282173A1
(en)
|
2009-08-17 |
2012-11-08 |
Forerunner Pharma Research Co., Ltd. |
Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
|
|
US8076097B2
(en)
|
2009-08-19 |
2011-12-13 |
Saladax Biomedical Inc. |
Imatinib immunoassay
|
|
US20130053405A1
(en)
|
2009-10-06 |
2013-02-28 |
Ulrich Hersel |
Carrier linked paliperidone prodrugs
|
|
EP2343296A1
(en)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
A process for the purification of paliperidone
|
|
CA2927380C
(en)
|
2009-12-31 |
2017-07-04 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
|
WO2011112657A1
(en)
|
2010-03-11 |
2011-09-15 |
Kempharm, Inc. |
Fatty acid conjugates of quetiapine, process for making and using the same
|
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
|
US8088594B2
(en)
*
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
*
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
CN102276592B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法、分析方法
|
|
CN102276624B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法和高效液相色谱分析方法
|
|
EP2741778A1
(en)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
AU2012296949B2
(en)
|
2011-08-12 |
2016-09-15 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
WO2013088255A1
(en)
|
2011-12-15 |
2013-06-20 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
BR112015003393A2
(pt)
|
2012-08-16 |
2017-07-04 |
Janssen Pharmaceutica Nv |
pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n
|
|
CA2882489A1
(en)
*
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone haptens and use thereof
|
|
AU2013305879B2
(en)
|
2012-08-21 |
2017-10-12 |
Saladax Biomedical Inc. |
Antibodies to aripiprazole and use thereof
|
|
PL3663317T3
(pl)
|
2012-08-21 |
2023-06-05 |
Janssen Pharmaceutica Nv |
Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
|
|
AU2013305930B2
(en)
*
|
2012-08-21 |
2017-08-24 |
Saladax Biomedical Inc. |
Haptens of paliperidone
|
|
WO2014031645A1
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc |
Antibodies to risperidone haptens and use thereof
|
|
CN110054694B
(zh)
|
2012-08-21 |
2024-02-20 |
詹森药业有限公司 |
阿立哌唑半抗原的抗体及其用途
|
|
JP6216926B2
(ja)
|
2012-08-21 |
2017-10-25 |
ヤンセン ファーマシューティカ エヌ．ベー． |
オランザピンに対する抗体及びその使用
|
|
CA2882454C
(en)
|
2012-08-21 |
2020-08-11 |
Matthew Garrett DONAHUE |
Haptens of olanzapine
|
|
HK1211958A1
(en)
*
|
2012-08-21 |
2016-06-03 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone and use thereof
|
|
PL3321254T3
(pl)
|
2012-08-21 |
2021-01-11 |
Janssen Pharmaceutica Nv |
Hapteny arypiprazolu i ich zastosowanie w testach immunologicznych
|
|
PL3333195T3
(pl)
|
2012-08-21 |
2021-02-22 |
Janssen Pharmaceutica Nv |
Przeciwciała względem kwetiapiny i ich zastosowania
|
|
US20140057303A1
(en)
|
2012-08-21 |
2014-02-27 |
Janssen Pharmaceutica Nv |
Antibodies to Olanzapine Haptens and Use Thereof
|
|
EP2888263B1
(en)
*
|
2012-08-21 |
2018-05-09 |
Janssen Pharmaceutica NV |
Haptens of risperidone and paliperidone
|
|
EP3305784B1
(en)
|
2012-08-21 |
2020-08-12 |
Janssen Pharmaceutica NV |
Haptens of quetiapine for use in immunoassays
|
|
PT3462173T
(pt)
|
2012-08-21 |
2021-04-28 |
Janssen Pharmaceutica Nv |
Anticorpos contra risperidona e utilização dos mesmos
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
AU2016372069A1
(en)
|
2015-12-17 |
2018-06-07 |
Saladax Biomedical Inc. |
Antibodies to risperidone and use thereof
|